Two-Year Follow-Up Study of Patients with Neovascular Age-Related Macular Degeneration Undergoing Anti-VEGF Treatment during the COVID-19 Pandemic

Two-Year Follow-Up Study of Patients with Neovascular Age-Related Macular Degeneration Undergoing Anti-VEGF Treatment during the COVID-19 Pandemic

Background: regular intravitreal anti-vascular endothelial growth factor (VEGF) treatment is crucial for patients with neovascular age-related macular degeneration (nAMD), and delayed treatment can exacerbate disease progression. Methods: we compared the outcomes of on-time versus delayed intravitre...

Full description

Bibliographic Details
Main Authors: Jae-Gon Kim, Yu Cheol Kim, Kyung Tae Kang
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
vascular endothelial growth factors
COVID-19
macular degeneration
Online Access:https://www.mdpi.com/2077-0383/13/3/867

Internet

https://www.mdpi.com/2077-0383/13/3/867

Similar Items